Etodolac

依托度酸

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameEtodolac
Drug Alias Nameetodolaco乙哚乙酸Etodolic acid艾雷克etodolacum +[15] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclooxygenases inhibitors
TargetsCyclooxygenases
Therapy Area/IndicationsFastingAcute PainPain +[8] 
Global Approved IndicationsPainOsteoarthritisArthritis, Rheumatoid
Approved Indications in ChinaOsteoarthritisArthritis, Rheumatoid
Original Approved Country/TerritoryUnited States
Original Approved Date1991/01/31
Country/TerritoryUnited StatesEgyptBrazil +[6] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesWyeth-Ayerst LaboratoriesPharos University in Alexandria
Inactive CompaniesHanmi Pharmaceutical Co LtdIpca Laboratories LtdWyeth Pharmaceuticals Inc +[4] 
Active IndicationsOsteoarthritis, KneeOsteoarthritisArthritis, Rheumatoid
Inactive IndicationsFastingAcute PainPain +[5] 

Other Information

ATC CodeM01AB08
Related LinksWikipediaDrugBankKEGG